Regeneron and Intellia Announce Expanded Research Collaboration to Develop CRISPR-Based Therapies for the Treatment of Neurological and Muscular Diseases tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.
TARRYTOWN, N.Y., Sept. 25, 2023 Regeneron Pharmaceuticals, Inc. today announced that it has successfully completed its acquisition of Decibel Therapeutics, Inc., strengthening the company’s.